In detail, authors demonstrated a statistically significant association between AQP1 expression and poor chemotherapy omental response (CRS1-2), suggesting that AQP1 could represent a predictive biomarker of platinum resistance in ovarian cancer. This evidence concerns the gene AQP1 and ovarian carcinoma.